Leerink Global Healthcare Conference 2026 March 11, 2026 10:00 AM EDTCompany ParticipantsScott Ullem - Corporate ...
Edwards Lifesciences Corporation ( EW) Barclays 28th Annual Global Healthcare Conference March 10, 2026 10:00 AM EDT ...
The global Structural Heart Devices Market was valued at USD 5.21 billion in 2018, reached USD 6.68 billion in 2024, and is anticipated to reach USD 12.93 billion by 2032, registering a CAGR of 8.65% ...
The "Structural Heart Devices Market - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032" report has been added to the Credence Research ...
The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977. Despite careful lesion selection, the initial equipment consisted of ...
Edwards Lifesciences (EW) grew TAVR sales 12.4% to $1.15B while Boston Scientific (BSX) exited TAVR entirely for cardiovascular diversification. Boston Scientific’s operating income surged 384.5% to ...
Add Yahoo as a preferred source to see more of our stories on Google. Edwards Lifesciences' Sapien 3 Ultra system. The artificial heart valve is pushed through the blood vessels via a catheter and ...
In December, Edwards Lifesciences persuaded CMS to publish an updated tracking sheet for TAVR national coverage analysis, causing the agency to reconsider its previous stance on covering transcatheter ...
Medtronic has plans to purchase $90 million worth of shares in Anteris Technologies Global, a company that specializes in the development of transcatheter aortic valve replacement devices. Medtronic’s ...
SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those after surgical aortic valve replacement (SAVR) in low-risk patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results